annual operating profit:
-$209.59M-$42.05M(-25.10%)Summary
- As of today (June 18, 2025), KROS annual operating income is -$209.59 million, with the most recent change of -$42.05 million (-25.10%) on December 31, 2024.
- During the last 3 years, KROS annual operating profit has fallen by -$153.22 million (-271.80%).
- KROS annual operating profit is now -15766.39% below its all-time high of -$1.32 million, reached on December 31, 2018.
Performance
KROS Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
$152.04M+$204.06M(+392.29%)Summary
- As of today (June 18, 2025), KROS quarterly operating income is $152.04 million, with the most recent change of +$204.06 million (+392.29%) on March 31, 2025.
- Over the past year, KROS quarterly operating profit has increased by +$200.52 million (+413.59%).
- KROS quarterly operating profit is now at all-time high.
Performance
KROS quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
-$9.07M+$200.52M(+95.67%)Summary
- As of today (June 18, 2025), KROS TTM operating income is -$9.07 million, with the most recent change of +$200.52 million (+95.67%) on March 31, 2025.
- Over the past year, KROS TTM operating profit has increased by +$168.08 million (+94.88%).
- KROS TTM operating profit is now -238.76% below its all-time high of -$2.68 million, reached on March 31, 2019.
Performance
KROS TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
KROS Operating profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -25.1% | +413.6% | +94.9% |
3 y3 years | -271.8% | +730.2% | +86.0% |
5 y5 years | -1994.9% | +1547.5% | +49.1% |
KROS Operating profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -271.8% | at low | at high | +359.2% | at high | +95.7% |
5 y | 5-year | -1994.9% | at low | at high | +359.2% | at high | +95.7% |
alltime | all time | <-9999.0% | at low | at high | +359.2% | -238.8% | +95.7% |
KROS Operating profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $152.04M(-392.3%) | -$9.07M(-95.7%) |
Dec 2024 | -$209.59M(+25.1%) | -$52.02M(-11.3%) | -$209.59M(+3.9%) |
Sep 2024 | - | -$58.66M(+16.3%) | -$201.63M(+8.3%) |
Jun 2024 | - | -$50.44M(+4.0%) | -$186.26M(+5.1%) |
Mar 2024 | - | -$48.48M(+10.1%) | -$177.16M(+5.7%) |
Dec 2023 | -$167.54M(+55.5%) | -$44.05M(+1.8%) | -$167.54M(+7.8%) |
Sep 2023 | - | -$43.28M(+4.7%) | -$155.45M(+13.9%) |
Jun 2023 | - | -$41.34M(+6.3%) | -$136.44M(+11.4%) |
Mar 2023 | - | -$38.87M(+21.6%) | -$122.45M(+13.7%) |
Dec 2022 | -$107.71M(+91.1%) | -$31.96M(+31.7%) | -$107.71M(+33.6%) |
Sep 2022 | - | -$24.27M(-11.3%) | -$80.61M(+5.3%) |
Jun 2022 | - | -$27.35M(+13.4%) | -$76.54M(+18.2%) |
Mar 2022 | - | -$24.13M(+395.8%) | -$64.73M(+14.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$56.37M(+27.5%) | -$4.87M(-75.9%) | -$56.37M(-9.6%) |
Sep 2021 | - | -$20.20M(+30.0%) | -$62.34M(+15.3%) |
Jun 2021 | - | -$15.54M(-1.4%) | -$54.09M(+9.4%) |
Mar 2021 | - | -$15.77M(+45.6%) | -$49.46M(+11.9%) |
Dec 2020 | -$44.20M(+341.7%) | -$10.83M(-9.3%) | -$44.20M(+22.4%) |
Sep 2020 | - | -$11.95M(+9.5%) | -$36.09M(+36.3%) |
Jun 2020 | - | -$10.91M(+3.9%) | -$26.47M(+48.5%) |
Mar 2020 | - | -$10.50M(+285.0%) | -$17.83M(+78.2%) |
Dec 2019 | -$10.01M(+657.4%) | -$2.73M(+17.3%) | -$10.01M(+37.5%) |
Sep 2019 | - | -$2.33M(+2.3%) | -$7.28M(+47.0%) |
Jun 2019 | - | -$2.27M(-15.1%) | -$4.95M(+84.9%) |
Mar 2019 | - | -$2.68M | -$2.68M |
Dec 2018 | -$1.32M | - | - |
FAQ
- What is Keros Therapeutics annual operating income?
- What is the all time high annual operating profit for Keros Therapeutics?
- What is Keros Therapeutics annual operating profit year-on-year change?
- What is Keros Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Keros Therapeutics?
- What is Keros Therapeutics quarterly operating profit year-on-year change?
- What is Keros Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Keros Therapeutics?
- What is Keros Therapeutics TTM operating profit year-on-year change?
What is Keros Therapeutics annual operating income?
The current annual operating profit of KROS is -$209.59M
What is the all time high annual operating profit for Keros Therapeutics?
Keros Therapeutics all-time high annual operating income is -$1.32M
What is Keros Therapeutics annual operating profit year-on-year change?
Over the past year, KROS annual operating income has changed by -$42.05M (-25.10%)
What is Keros Therapeutics quarterly operating income?
The current quarterly operating profit of KROS is $152.04M
What is the all time high quarterly operating profit for Keros Therapeutics?
Keros Therapeutics all-time high quarterly operating income is $152.04M
What is Keros Therapeutics quarterly operating profit year-on-year change?
Over the past year, KROS quarterly operating income has changed by +$200.52M (+413.59%)
What is Keros Therapeutics TTM operating income?
The current TTM operating profit of KROS is -$9.07M
What is the all time high TTM operating profit for Keros Therapeutics?
Keros Therapeutics all-time high TTM operating income is -$2.68M
What is Keros Therapeutics TTM operating profit year-on-year change?
Over the past year, KROS TTM operating income has changed by +$168.08M (+94.88%)